Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 


EU to release €11.7 million for diabetes research


The European Commission has announced the launch of a five-year €11.7 million “Integrated project” to look into the treatment of obesity, one of the main causes of diabetes. The project will help identify brain mechanisms affecting obesity. The announcement ties in with World Diabetes Day on November 14th, which aims to raise public awareness of the causes, symptoms, treatment and complications associated with diabetes. The European Union has been supporting diabetes research for several years through its Research Framework Programmes. During the last four years alone, it has invested €40 million in 19 projects in this field. The 6th Framework Programme (FP6 2003-2006) allocates €2.225 billion to health research, including diabetes. The Integrated project on obesity and diabetes includes 24 partners from ten European countries. It is now being negotiated, and it will start its ambitious research activities early 2004.

“Considerable progress in treating diabetes has been achieved through innovative research but more research is needed to address the unmet needs of patients,” says European Research Commissioner Philippe Busquin. “Obesity ranks high among the causes of diabetes. It is a major risk factor and the reduction of weight often improves blood sugar control, thereby helping in the treatment of diabetes. This new research project is a first example of the European Research Area in action in the field of diabetes. Major players in this medical area will join forces and help make a change in the treatment of this illness at European level.”

... mehr zu:

Diabetes on the rise in Europe

The number of European citizens suffering from diabetes is rising. Most patients are affected by “type 2” diabetes. World Diabetes Day, supported by the World Health Organisation (WHO) and the International Diabetes Federation (IDF), is an annual awareness campaign to keep up the fight against diabetes. Many people do not even know they have high blood sugar levels and diabetes. Untreated diabetes can lead to serious long-term consequences and this year’s World Diabetes Day is focusing on kidney disease.

One of the reasons more and more Europeans are developing diabetes is that people’s average weight has increased. With increasing weight and obesity, in many cases the body is no longer able to maintain normal (low) blood sugar levels. A promising treatment of “type 2” diabetes is weight reduction. However, it is often difficult for patients to reduce weight and even more difficult to avoid a rapid rebound after weight reduction, for instance at the end of a diet.

EU funded research to combat diabetes

On a European Union level, research funding is available through the multi-annual Framework Programmes. Through the Fifth Research Framework Programme (1998-2002) 19 projects related to diabetes were supported, covering a wide range of topics. The total funding for these projects was almost €40 million. The goal of the Sixth Research Framework Programme (FP6, 2002-2006) is to aid the creation of the European Research Area (ERA) through new funding instruments, Integrated Projects and Networks of Excellence.

Fresh money for diabetes research

The European Commission has tackled research needs in the field of diabetes and obesity with a first call for proposals earlier this year. Following evaluation, the Commission is now involved with negotiations to fund an Integrated Project with an EU contribution of €11.7 million. The scientific basis for the project under negotiation is the knowledge that specific brain regions play an important role in weight regulation. The project aims at investigating the details of the regulatory circuits and to exploit this knowledge for the validation of targets for the treatment of obesity.

To achieve this goal, the project brings together 24 partners from 10 European countries. It integrates advanced genomic approaches with detailed analysis of sample patient groups and genetic research in animal models. Over five years, the project aims at validating several novel targets for drug development in this field, which is of high importance for public health in Europe.

Further calls for proposals

Three further calls during the Sixth Framework Programme will help strengthen the European Research Area as regards to diabetes research for the benefit of patients. In addition to supporting research through the new funding instruments, further projects are being supported through the traditional instruments, which are smaller in scope and funding. Research on “type 1” diabetes will also be supported within FP6.

Fabio Fabbi | European Commission
Weitere Informationen:

Weitere Berichte zu: Diabetes

Weitere Nachrichten aus der Kategorie Förderungen Preise:

nachricht ERC Proof of Concept Grant soll Anwendung innovativer Haftstrukturen vorantreiben
19.03.2018 | INM - Leibniz-Institut für Neue Materialien gGmbH

nachricht DFG richtet 14 neue Schwerpunktprogramme ein - März 2018
16.03.2018 | Deutsche Forschungsgemeinschaft (DFG)

Alle Nachrichten aus der Kategorie: Förderungen Preise >>>

Die aktuellsten Pressemeldungen zum Suchbegriff Innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: „OLED Licht Forum" – zentraler Ansprechpartner für die Lichtquelle OLED

Das Fraunhofer-Institut für Organische Elektronik, Elektronenstrahl- und Plasmatechnik FEP, Forschungs- und Entwicklungsanbieter für OLED-Beleuchtungslösungen, ist seit 19. März 2018 Teil des neu gegründeten „OLED Licht Forums“ und präsentiert auf der light+building vom 18. – 23. März 2018, in Frankfurt a.M., in Halle 4.0 am Stand Nr. F91, neue OLED-Design- und Beleuchtungslösungen.

Sie vereint die große Leidenschaft für die OLED-Beleuchtung (organische Leuchtdioden) mit all ihren Facetten und Anwendungsmöglichkeiten. Daher haben sich...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

Im Focus: Winzige Zell-Implantate funktionieren auch in vivo

Einem interdisziplinären Team der Universität Basel ist es erstmals gelungen, steuerbare künstliche Organellen erfolgreich in die Zellen lebender Zebrafischembryonen einzuschleusen. Der innovative Ansatz, künstliche Organellen als Zell-Implantate zu nutzen, verspricht neue Perspektiven bei der Behandlung verschiedener Krankheiten, wie die Autoren in ihrer Veröffentlichung in «Nature Communications» berichten.

In den Zellen höherer Lebewesen erfüllen Organellen wie der Zellkern oder die Mitochondrien verschiedene lebensnotwendige Funktionen. Im Verbund mit dem Swiss...

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

Im Focus: Bewegungskontrolle mit Fotopigmenten

Forscher der Universität Göttingen entdecken zusätzliche Funktion von Opsinen

Die Fotorezeptoren in den Augen von Tieren fangen Licht mithilfe von Fotopigmenten ein. Forscher der Universität Göttingen haben nun entdeckt, dass diese...

Alle Focus-News des Innovations-reports >>>



Industrie & Wirtschaft

Hybrid-elektrisch angetriebene Verkehrsflugzeuge – Zukunft oder Fiktion?

20.03.2018 | Veranstaltungen

Konferenz zur virtuellen Realität kommt nach Reutlingen

19.03.2018 | Veranstaltungen

Veranstaltungen zur Digitalisierung in der Weiterbildung

19.03.2018 | Veranstaltungen

Wissenschaft & Forschung
Weitere VideoLinks im Überblick >>>
Aktuelle Beiträge

„OLED Licht Forum" – zentraler Ansprechpartner für die Lichtquelle OLED

20.03.2018 | Messenachrichten

Wie sich Muskelkraft auf das Skelett überträgt

20.03.2018 | Biowissenschaften Chemie

Phoenix Contact Innovation Ventures ist Hauptinvestor bei Finanzierung eines kanadischen Netzwerkspezialisten

20.03.2018 | Unternehmensmeldung

Weitere B2B-VideoLinks
im innovations-report
in Kooperation mit academics